To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer
Clinical trial NCT07364422 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07364422
- Sponsor
- Onconic Therapeutics Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-27
- Primary completion
- 2026-02-28
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.